Feng Pan

1.8k citations

57 papers · 1.2k indexed · h-index 23

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation

Papers in ⓘ

Immunology and Allergy 5
- Cell Adhesion Molecules Research 5
Cancer Research 12
- Cancer, Hypoxia, and Metabolism 5

Co-authors: Wei Gu (3 shared papers)Houjie Liang (6 shared papers)En‐Min Li (11 shared papers)Li‐Yan Xu (10 shared papers)Robert H. Singer (1 shared paper)Ganfeng Xie (4 shared papers)Yang Sun (5 shared papers)Wei Yi (5 shared papers)
Journals: Cell Death and Disease (3 papers)BioMed Research International (2 papers)Cancer Cell International (2 papers)Clinical & Translational Oncology (1 paper)Clinical Cancer Research (1 paper)
Partner nations: China United States Switzerland

In The Last Decade

Feng Pan

56 papers receiving 1.2k citations

Peers

Countries citing papers authored by Feng Pan

Since Specialization

Citations

This map shows the geographic impact of Feng Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Pan more than expected).

Fields of papers citing papers by Feng Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Pan. The network helps show where Feng Pan may publish in the future.

Co-authors

The 25 scholars most cited alongside Feng Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feng Pan Line = papers co-authored together Feng Pan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Synergistic Antitumor Effect of Dichloroacetate in Combination with 5‐Fluorouracil in Colorectal Cancer BioMed Research International ·Jingtao Tong, Ganfeng Xie, Jinxia He, Jianjun Li, Feng Pan, Houjie Liang	2011	85
2	Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis Cell Death and Disease ·Dajun Zhao, Feng Pan, Yang Sun, Zhigang Qin, Zhengbin Zhang, Yanzhen Tan, Erhe Gao, Wayne Bond Lau, Xinliang Ma, Jian Yang, Shiqiang Yu, Xuezeng Xu, YI Ding-hua, Wei Yi	2018	67
3	Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway Life Sciences ·Zhengbin Zhang, Yanzhen Tan, Liwen Zhu, Bing Zhang, Feng Pan, Erhe Gao, Chennian Xu, Xiaoming Wang, Wei Yi, Yang Sun	2019	65
4	Involvement of CYR61 and CTGF in the Fascin-Mediated Proliferation and Invasiveness of Esophageal Squamous Cell Carcinomas Cells American Journal Of Pathology ·Jian‐Jun Xie, Li‐Yan Xu, Jian‐Yi Wu, Zhong‐Ying Shen, Qing Zhao, Zepeng Du, Zhuo Lv, Wei Gu, Feng Pan, Xiu‐E Xu, Dong Xie, En‐Min Li	2010	61
5	Blocking β-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells Journal of Cell Science ·Wei Gu, Feng Pan, Robert H. Singer	2009	60
6	C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress Cell Death and Disease ·Bing Zhang, Ping Zhang, Yanzhen Tan, Feng Pan, Zhengbin Zhang, Hongliang Liang, Weixun Duan, Zhenxiao Jin, Xiaowu Wang, Jincheng Liu, Erhe Gao, Shiqiang Yu, YI Ding-hua, Yang Sun, Wei Yi	2019	57
7	ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma Oncotarget ·Jian‐Jun Xie, Yang‐Min Xie, Bo Chen, Feng Pan, Jincheng Guo, Qing Zhao, Jin‐Hui Shen, Zhi‐Yong Wu, Jian‐Yi Wu, Li‐Yan Xu, En‐Min Li	2014	54
8	Protein‐coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma Cancer Communications ·Jincheng Guo, Yang Wu, Yang Chen, Feng Pan, Zhi‐Yong Wu, Jiasheng Zhang, Jian‐Yi Wu, Xiu‐E Xu, Jian‐Mei Zhao, En‐Min Li, Yi Zhao, Li‐Yan Xu	2018	44
9	Endogenous Axon Guiding Chemorepulsant Semaphorin-3F Inhibits the Growth and Metastasis of Colorectal Carcinoma Clinical Cancer Research ·Feng Wu, Qi Zhou, Jing Yang, Guangjie Duan, Juanjuan Ou, Rong Zhang, Feng Pan, Qiuping Peng, Hong Kee Tan, Yi‐Fang Ping, You‐Hong Cui, Cheng Qian, Xiao-Chu Yan, Xiu‐Wu Bian	2011	41
10	Neuroprotection by plumbagin involves BDNF-TrkB-PI3K/Akt and ERK1/2/JNK pathways in isoflurane-induced neonatal rats Journal of Pharmacy and Pharmacology ·Junhui Yuan, Feng Pan, Jie Chen, Cai-Er Chen, Deng-Pan Xie, Xing-Zhu Jiang, Sujuan Guo, Jun Zhou	2017	41
11	Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPARγ/PTEN/AKT pathway in differentiated human embryonic stem cells Food and Chemical Toxicology ·Haiqin Fang, Weiting Fang, Hanwen Cao, Sha Luo, Jingdong Cong, Sana Liu, Feng Pan, Xudong Jia	2019	38
12	The activation of GPER inhibits cells proliferation, invasion and EMT of triple-negative breast cancer via CD151/miR-199a-3p bio-axis. PubMed ·Ruiyan Huang, Junbai Li, Feng Pan, Baofan Zhang, Yufeng Yao	2020	36
13	miR-125b inhibited epithelialal–mesenchymal transition of triple-negative breast cancer by targeting MAP2K7 OncoTargets and Therapy ·Zhaojun Chen, Liquan Hong, Feng Pan, Huifen Jiang, Lahong Zhang, Yuhua Liu, Chengsong Cai, Chun‐Zhen Hua, Xian Luo, Jin-Hua Sun	2016	34
14	The effect of focal adhesion kinase gene silencing on 5‐fluorouracil chemosensitivity involves an Akt/NF‐κB signaling pathway in colorectal carcinomas International Journal of Cancer ·Yuying Chen, Zhanxiang Wang, Pingan Chang, Liuxin Xiang, Feng Pan, Jianjun Li, Jinyan Jiang, Lan Zou, Yang Li, Zhiheng Bian, Houjie Liang	2009	33
15	Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker Oncology Reports ·Lahong Zhang, Zhaojun Chen, Dan Xue, Qi Zhang, Xiyong Liu, Frank Luh, Liquan Hong, Hang Zhang, Feng Pan, Yuhua Liu, Peiguo Chu, Shu Zheng, Guo‐qiang Lou, Yun Yen	2016	32
16	Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor Human Pathology ·Wang‐Kai Fang, Wei Gu, En‐Min Li, Zhi‐Yong Wu, Zhong-Ying Shen, Jin‐Hui Shen, Jian‐Yi Wu, Feng Pan, Zhuo Lv, Xiu‐E Xu, Qiao Huang, Li‐Yan Xu	2010	31
17	Genome-wide analysis of poplar VQ gene family and expression profiling under PEG, NaCl, and SA treatments Tree Genetics & Genomes ·Wenyuan Chu, Bin Liu, Yujiao Wang, Feng Pan, Zhu Chen, Hanwei Yan, Yan Xiang	2016	26
18	C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction Cell Death and Disease ·Zhengbin Zhang, Liwen Zhu, Feng Pan, Yanzhen Tan, Bing Zhang, Erhe Gao, Xiaowu Wang, Chongxi Fan, Xiaoming Wang, Wei Yi, Yang Sun	2019	25
19	Promoter Methylation Profiles between Human Lung Adenocarcinoma Multidrug Resistant A549/Cisplatin (A549/DDP) Cells and Its Progenitor A549 Cells Biological and Pharmaceutical Bulletin ·Ruiling Guo, Guoming Wu, Haidong Li, Pin Qian, Juan Han, Feng Pan, LI Wen-bi, Jin Li, Fuyun Ji	2013	24
20	Silencing Fibronectin Extra Domain A Enhances Radiosensitivity in Nasopharyngeal Carcinomas Involving an FAK/Akt/JNK Pathway International Journal of Radiation OncologyBiologyPhysics ·Juanjuan Ou, Feng Pan, Peiliang Geng, Xing Wei, Ganfeng Xie, Jia Deng, Xueli Pang, Houjie Liang	2011	23

About Feng Pan

Feng Pan is a scholar working on Immunology and Allergy, Cancer Research, Aging, Molecular Biology and Developmental Neuroscience, having authored 57 papers that have together received 1.2k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (9 papers), RNA modifications and cancer (8 papers), Cell Adhesion Molecules Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related gene regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Mesenchymal stem cell research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (323 citations), Molecular Biology (728 citations), Immunology and Allergy (48 citations), Oncology (192 citations) and Cell Biology (94 citations). Feng Pan has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Wei Gu, Houjie Liang, En‐Min Li, Li‐Yan Xu, Robert H. Singer, Ganfeng Xie, Yang Sun, Wei Yi, Erhe Gao and Yanzhen Tan. Their work appears in journals such as Cell Death and Disease, BioMed Research International, Cancer Cell International, Clinical & Translational Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact